Point of care testing for INR monitoring: where are we now?

ET Murray, DA Fitzmaurice… - British journal of …, 2004 - Wiley Online Library
Point of care (POC, or near patient) testing for measurement of the international normalized
ratio (INR) has facilitated the devolution of service delivery from the traditional hospital …

Point‐of‐care testing in haemostasis

DJ Perry, DA Fitzmaurice, S Kitchen… - British Journal of …, 2010 - Wiley Online Library
Point‐of‐care testing (POCT) in haematology has seen a significant increase in both the
spectrum of tests available and the number of tests performed annually. POCT is frequently …

Screening for atrial fibrillation: a report of the AF-SCREEN International Collaboration

…, D Conen, J Engdahl, L Fauchier, DA Fitzmaurice… - Circulation, 2017 - Am Heart Assoc
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first diagnosed
at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent …

Is the international normalised ratio (INR) reliable? A trial of comparative measurements in hospital laboratory and primary care settings.

FD Hobbs, DA Fitzmaurice, ET Murray… - Journal of clinical …, 1999 - jcp.bmj.com
AIM: To determine the reliability of international normalised ratio (INR) measurement in
primary care by practice nurses using near patient testing (NPT), in comparison with results …

A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of …

FDR Hobbs, DA Fitzmaurice, J Mant, E Murray… - 2005 - repository.cam.ac.uk
OBJECTIVES: To determine the most cost-effective method of screening for atrial fibrillation (AF)
in the population aged 65 years and over, as well as its prevalence and incidence in …

[HTML][HTML] Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational …

AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice… - PloS one, 2013 - journals.plos.org
Fitzmaurice received honoraria from Bayer, BI, and sanofi-aventis. Dr. Goldhaber received
research grants from BI, BMS, Eisai, EKOS, Johnson & Johnson, and sanofi-aventis, and …

Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial

DA Fitzmaurice, FDR Hobbs, S Jowett, J Mant… - Bmj, 2007 - bmj.com
Objectives To assess whether screening improves the detection of atrial fibrillation (cluster
randomisation) and to compare systematic and opportunistic screening. Design Multicentred …

International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD)

AK Kakkar, I Mueller, JP Bassand, DA Fitzmaurice… - American heart …, 2012 - Elsevier
BACKGROUND: Atrial fibrillation (AF) is associated with high rates of morbidity and mortality.
Patients with AF carry a fivefold increased risk of stroke and the risk of death from AF-…

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

…, AJ Camm, F Cools, DA Fitzmaurice… - European heart …, 2016 - academic.oup.com
Aims The relationship between outcomes and time after diagnosis for patients with non-valvular
atrial fibrillation (NVAF) is poorly defined, especially beyond the first year. Methods and …

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

…, D Atar, JP Bassand, E Berge, F Cools, DA Fitzmaurice… - Heart, 2017 - heart.bmj.com
Objective We studied evolving antithrombotic therapy patterns in patients with newly diagnosed
non-valvular atrial fibrillation (AF) and ≥1 additional stroke risk factor between 2010 and …